Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
Official title:
Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction: a Randomized, Double-blind, Basic-treatment-loading, Placebo-controlled, Multicenter Phase Ⅱ Clinical Trial
Main objective: To evaluate the efficacy, safety and clinical dose exploration of Qishen Yiqi dripping pills in the treatment of chronic heart failure with preserved ejection fraction. Exploratory research objective: To explore the changes of endogenous substances in vivo before and after drug administration, to interpret the mechanism of drug action through metabolomics and systems biology methods, and to find potential clinical biomarkers for exploratory subgroup analysis of clinical trials.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03547583 -
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
|
Phase 2 |